- Home
- MCHX vs PLRX Comparison
MCHX vs PLRX Comparison
Compare MCHX & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCHX
- PLRX
- Stock Information
- Founded
- MCHX 2003
- PLRX 2015
- Country
- MCHX United States
- PLRX United States
- Employees
- MCHX N/A
- PLRX 171
- Industry
- MCHX Business Services
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- MCHX Consumer Discretionary
- PLRX Health Care
- Exchange
- MCHX Nasdaq
- PLRX Nasdaq
- Market Cap
- MCHX 84.3M
- PLRX 104.4M
- IPO Year
- MCHX 2004
- PLRX 2020
- Fundamental
- Price
- MCHX $2.13
- PLRX $1.66
- Analyst Decision
- MCHX
- PLRX Hold
- Analyst Count
- MCHX 0
- PLRX 10
- Target Price
- MCHX N/A
- PLRX $9.79
- AVG Volume (30 Days)
- MCHX 18.4K
- PLRX 1.2M
- Earning Date
- MCHX 08-12-2025
- PLRX 08-15-2025
- Dividend Yield
- MCHX N/A
- PLRX N/A
- EPS Growth
- MCHX N/A
- PLRX N/A
- EPS
- MCHX N/A
- PLRX N/A
- Revenue
- MCHX $47,951,000.00
- PLRX N/A
- Revenue This Year
- MCHX $5.77
- PLRX N/A
- Revenue Next Year
- MCHX N/A
- PLRX N/A
- P/E Ratio
- MCHX N/A
- PLRX N/A
- Revenue Growth
- MCHX N/A
- PLRX N/A
- 52 Week Low
- MCHX $1.26
- PLRX $1.10
- 52 Week High
- MCHX $2.40
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- MCHX 61.52
- PLRX 65.75
- Support Level
- MCHX $1.89
- PLRX $1.45
- Resistance Level
- MCHX $2.04
- PLRX $1.79
- Average True Range (ATR)
- MCHX 0.09
- PLRX 0.12
- MACD
- MCHX -0.00
- PLRX 0.02
- Stochastic Oscillator
- MCHX 96.00
- PLRX 86.96
About MCHX Marchex Inc. Class B
Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.